Table 5. Association of alcohol drinking and tobacco smoking with risk of haematological malignancies: trend analysis excluding the first 3 years of follow-up.
Alcohol | Smoking | |||||||
---|---|---|---|---|---|---|---|---|
Trend among drinkers
a
|
Trend among never- or current smokers
b
|
|||||||
Excluding first 3 years of follow-up | Cases | RR | 95% CI | P trend | Cases | RR | 95% CI | P trend |
All haematological malignancies | ||||||||
ICD-O-3 classification | 5235 | 0.94 | 0.89, 0.98 | 0.006 | 4825 | 1.14 | 1.09, 1.18 | <0.001 |
ICD-10 classification | 4528 | 0.92 | 0.87, 0.97 | 0.001 | 4170 | 1.07 | 1.03, 1.12 | 0.001 |
Subgroups of ICD-O-3 classification | ||||||||
ICD-O-3 haematological malignanciesc | Phet=0.01 | Phet<0.001 | ||||||
Lymphoid | 4031 | 0.91 | 0.86, 0.96 | <0.001 | 3721 | 1.07 | 1.02, 1.12 | 0.006 |
Myeloid | 1177 | 1.04 | 0.95, 1.15 | 0.4 | 1082 | 1.36 | 1.26, 1.47 | <0.001 |
ICD-O-3 lymphoid malignancies | Phet=0.2 | Phet<0.001 | ||||||
Hodgkin lymphoma | 129 | 1.07 | 0.79, 1.44 | 0.7 | 152 | 1.57 | 1.29, 1.90 | <0.001 |
Mature B cell | 3045 | 0.90 | 0.84, 0.95 | <0.001 | 2774 | 1.00 | 0.95, 1.06 | 0.9 |
Mature T cell | 118 | 1.19 | 0.88, 1.61 | 0.3 | 88 | 1.34 | 1.02, 1.77 | 0.03 |
Other/unspecified lymphoid | 739 | 0.88 | 0.78, 1.00 | 0.05 | 707 | 1.17 | 1.06, 1.30 | 0.002 |
ICD-O-3 mature B-cell malignancies | Phet=0.01 | Phet=0.2 | ||||||
Diffuse large B-cell lymphoma | 699 | 0.83 | 0.72, 0.95 | 0.005 | 650 | 1.03 | 0.92, 1.16 | 0.6 |
Follicular lymphoma | 590 | 0.88 | 0.76, 1.02 | 0.08 | 542 | 1.08 | 0.96, 1.22 | 0.2 |
Plasma cell neoplasms | 901 | 0.83 | 0.74, 0.94 | 0.002 | 820 | 0.92 | 0.83, 1.02 | 0.1 |
CLL/SLL | 540 | 0.97 | 0.83, 1.12 | 0.6 | 494 | 0.96 | 0.84, 1.10 | 0.6 |
Other/unspecified mature B cell | 315 | 1.19 | 0.99, 1.43 | 0.07 | 268 | 1.10 | 0.93, 1.30 | 0.3 |
ICD-O-3 myeloid malignanciesc | Phet=0.4 | Phet<0.001 | ||||||
Acute myeloid leukaemia | 343 | 0.98 | 0.81, 1.17 | 0.8 | 311 | 1.07 | 0.91, 1.26 | 0.4 |
Myeloproliferative/myelodysplastic disease | 821 | 1.07 | 0.95, 1.21 | 0.2 | 759 | 1.48 | 1.35, 1.62 | <0.001 |
Subgroups of ICD-10 classification | ||||||||
ICD-10 haematological malignancies | Phet=0.06 | Phet<0.001 | ||||||
Hodgkin lymphoma | 129 | 1.07 | 0.79, 1.44 | 0.7 | 152 | 1.57 | 1.29, 1.90 | <0.001 |
Non-Hodgkin lymphoma | 2435 | 0.89 | 0.83, 0.96 | 0.001 | 2227 | 1.12 | 1.05, 1.18 | <0.001 |
Myeloma | 947 | 0.86 | 0.76, 0.96 | 0.008 | 856 | 0.92 | 0.83, 1.02 | 0.1 |
Leukaemia | 1017 | 1.03 | 0.93, 1.14 | 0.6 | 935 | 1.03 | 0.94, 1.13 | 0.5 |
Abbreviations: Cases, number of incident cases; CI, confidence interval; CLL/SLL, chronic lymphocytic leukaemia/small lymphocytic lymphoma; ICD-O-3, International Classification of Diseases for Oncology 3rd edition; ICD-10, International Classification of Diseases 10th revision; Phet result of χ2 contrast test for heterogeneity of trends between subtypes; Ref, referent; Ptrend, result of test for categorical trend; RR, relative risk.
Myeloproliferative/myelodysplastic disease includes chronic myeloid leukaemia.
Relative risk per 10 g per day, adjusted for body mass index, height, smoking and socioeconomic status, and stratified by cancer registry region.
Relative risk per 10 cigarettes per day, adjusted for body mass index, height, alcohol consumption and socioeconomic status, and stratified by cancer registry region.
Excludes other/unspecified cases.